Force TJR QI 2014
Overview and benefits of Force TJR registry
UMassMedical School
Dr. David Ayers, Chair, UMass Memorial Orthopedics and Rehabilitation Dept.
CXAIR structuring data for inclusion in COSD for the NHSEmma Ordidge
Alongside many other changes occurring in the NHS lately, the way in which Cancer Services are reporting on their data has been reformed. The Government believe these changes are necessary requirements to improve patient outcomes for those diagnosed with Cancer, and will aid reaching the latest government target of saving over 5000 additional lives each year.
See how CXAIR can help solve the challenges of these requirements.
Analytics leader optimizing clinical & operational services with high integrity partnerships, frictionless processes and shared data. Tactful engineering manager (five years) delivering self service automated BI/data applications and analyses that drives service transformation towards benchmarked quality and efficiency outcomes, often across multiple delivery modes (inpatient, ASC, medical group, pharmacy, lab) and insurance contracts (providers, groups, products, ACOs). Expert (16 years) in developing data services into actionable/modifiable descriptive trends/variances, predictive, and prescriptive analytics to optimize healthcare service decision making.
The New War on Bugs: Crafting an Effective Antibiotic Stewardship Program
More than half of all hospital patients are treated with antibiotics and prescribing practices vary widely, even within hospitals. Efforts to rationalize antibiotic use have been stymied by delays in obtaining specific diagnoses, by the volume of prescriptions written each day and by the difficulty of extracting meaningful data from scattered clinical, laboratory and pharmacy records. But the push is on – from the White House, the CDC, infectious disease specialists, the industry – for more judicious use of antibiotics through antibiotic stewardship programs.
Hear how leading health care institutions have moved from education to active surveillance to intervention, reducing infections and lowering costs.
CXAIR structuring data for inclusion in COSD for the NHSEmma Ordidge
Alongside many other changes occurring in the NHS lately, the way in which Cancer Services are reporting on their data has been reformed. The Government believe these changes are necessary requirements to improve patient outcomes for those diagnosed with Cancer, and will aid reaching the latest government target of saving over 5000 additional lives each year.
See how CXAIR can help solve the challenges of these requirements.
Analytics leader optimizing clinical & operational services with high integrity partnerships, frictionless processes and shared data. Tactful engineering manager (five years) delivering self service automated BI/data applications and analyses that drives service transformation towards benchmarked quality and efficiency outcomes, often across multiple delivery modes (inpatient, ASC, medical group, pharmacy, lab) and insurance contracts (providers, groups, products, ACOs). Expert (16 years) in developing data services into actionable/modifiable descriptive trends/variances, predictive, and prescriptive analytics to optimize healthcare service decision making.
The New War on Bugs: Crafting an Effective Antibiotic Stewardship Program
More than half of all hospital patients are treated with antibiotics and prescribing practices vary widely, even within hospitals. Efforts to rationalize antibiotic use have been stymied by delays in obtaining specific diagnoses, by the volume of prescriptions written each day and by the difficulty of extracting meaningful data from scattered clinical, laboratory and pharmacy records. But the push is on – from the White House, the CDC, infectious disease specialists, the industry – for more judicious use of antibiotics through antibiotic stewardship programs.
Hear how leading health care institutions have moved from education to active surveillance to intervention, reducing infections and lowering costs.
Oncology Care Model (OCM) are willing to take on two-sided riskJessica Parker
Oncology practitioners in CMS’s Oncology care model (OCM) are willing to take on two-sided risk, according to the Community Oncology Alliance (COA) survey.
"If You Build It, They Will Come"--Building a physician referral based dental sleep medicine practice. 2015 presentation made to attendees at the 2015 National Meeting of the American Academy of Dental Sleep Medicine in Seattle.
Assassino Drogas e do Salão da Fama do Suplemento - Brasil 2015Louis Cady, MD
Nesta apresentação, o terceiro de três palestras Dr. Cady entregue em São Paulo, Brasil, Dr. Cady analisa os padrões críticos de interações com vários medicamentos psicotrópicos prescritos com freqüência (e outros). A ênfase é dada em como não cometer uma interação droga-droga óbvio, bem como evitando aqueles mais sutis. O foco então muda para suplementos: quais são os melhores, quais os que têm benefícios de saúde mental, e como evitar interações entre suplementos usados convencionalmente e medicamentos psiquiátricos.
Oncology Care Model (OCM) are willing to take on two-sided riskJessica Parker
Oncology practitioners in CMS’s Oncology care model (OCM) are willing to take on two-sided risk, according to the Community Oncology Alliance (COA) survey.
"If You Build It, They Will Come"--Building a physician referral based dental sleep medicine practice. 2015 presentation made to attendees at the 2015 National Meeting of the American Academy of Dental Sleep Medicine in Seattle.
Assassino Drogas e do Salão da Fama do Suplemento - Brasil 2015Louis Cady, MD
Nesta apresentação, o terceiro de três palestras Dr. Cady entregue em São Paulo, Brasil, Dr. Cady analisa os padrões críticos de interações com vários medicamentos psicotrópicos prescritos com freqüência (e outros). A ênfase é dada em como não cometer uma interação droga-droga óbvio, bem como evitando aqueles mais sutis. O foco então muda para suplementos: quais são os melhores, quais os que têm benefícios de saúde mental, e como evitar interações entre suplementos usados convencionalmente e medicamentos psiquiátricos.
How to Transition from Allopathic to Integrated Practice - IMM Brazil 2015Louis Cady, MD
In this lecture, Dr. Cady compares and contrasts the significance differences, both conceptually and practically, between the conventional practice of medicine and a more rational, functional, integrated approach. Tactical concepts and didactic tools to make the transition are reviewed.
"Killer Drugs & The Supplement Hall of Fame" - IMMH Brazil, 2015Louis Cady, MD
In this presentation, the third of three lectures Dr. Cady delivered in São Paulo, Brazil, Dr. Cady reviews the critical patterns of interactions with numerous frequently prescribed psychotropic medications (and others). Emphasis is given on how not to commit an obvious drug-drug interaction as well as avoiding more subtle ones. The focus then shifts to supplements: which ones are the best, which ones have mental health benefits, and how to avoid interactions between conventionally used supplements and psychiatric medications.
Information and Communication Technologies Transform the Practice of MedicineKamal Perera
Information and Communication Technologies Transform the Practice of Medicine:
Work shop : Presented by: Andrew Stranieri, Tony Sahama and Pathirage Kamal Perera
Parallel to 2nd International Conference on Ayurveda, Unani, Siddha and Traditional Medicine – 2014 and AYU – EXPO” organized by Institute of Indigenous Medicine, University of Colombo, Rajagiriya, Sri Lanka collaborate with University Grants Commission, Sri Lanka : 16-18 December 2014.
Force TJR Annual Report 2014Force TJR Annual Report 2014
Force TJR (Function and Outcomes Research for Comparative Effectiveness in Total Joint Replacement) Registry
UMass Medical School
Department of Orthopedics and Physical Rehabilitation
A Leading Patient Experience Survey Platform by MedStatix - White Labeled for...MedStatix, LLC
Improving Patient Experience. Improving Practice Performance.
MedStatix, LLC, offers a WHITE LABELED, cloud-based specialty-specific patient experience survey platform that is bundled and/or resold by leading EMR/EHRs and other integrated healthcare service providers as a value-add to their products.
The patient experience platform uses data science and predictive analytics learned from data hosted on the platform to enable healthcare providers to improve quality of care, patient retention rates and risk profiles of physician practices.
The patient experience platform pinpoints specific, actionable problems where practices can improve their service through its easy-to-implement, yet sophisticated technology solution for monitoring and measuring patient experience by each provider across an organization.
With over a decade delivering over one million patient surveys for over 25 pharmaceutical brands, as well as customer feedback platforms and analytics for Fortune-class brands, MedStatix enables their resellers to provide their customers with exceptional practice improvement opportunities.
Systematic review of quality standards for medical devices and practice measu...Pubrica
A systematic literature search performed in databases (Medline, Cochrane Library, Scopus, Embase, CRD York), selected journals and websites identified articles describing either a general MDR structure or the development process of specific registries.
Learn More : https://pubrica.com/services/research-services/systematic-review/
Reference: https://bit.ly/3MCXLOK
Why Pubrica:
When you order our services, we promise you the following – Plagiarism free | always on Time | 24*7 customer support | Written to international Standard | Unlimited Revisions support | Medical writing Expert | Publication Support | Bio statistical experts | High-quality Subject Matter Experts.
Contact us:
Web: https://pubrica.com/
Blog: https://pubrica.com/academy/
Email: sales@pubrica.com
WhatsApp : +91 9884350006
United Kingdom: +44-1618186353
Systematic review of quality standards for medical devices and practice measu...Pubrica
A systematic literature search performed in databases (Medline, Cochrane Library, Scopus, Embase, CRD York), selected journals and websites identified articles describing either a general MDR structure or the development process of specific registries.
Learn More : https://pubrica.com/services/research-services/systematic-review/
Reference: https://bit.ly/3MCXLOK
Why Pubrica:
When you order our services, we promise you the following – Plagiarism free | always on Time | 24*7 customer support | Written to international Standard | Unlimited Revisions support | Medical writing Expert | Publication Support | Bio statistical experts | High-quality Subject Matter Experts.
Contact us:
Web: https://pubrica.com/
Blog: https://pubrica.com/academy/
Email: sales@pubrica.com
WhatsApp : +91 9884350006
United Kingdom: +44-1618186353
US Healthcare QUALITY_ Dr. Elliot GoodmanLevi Shapiro
Presentation for mHealth Israel by Dr. Elliot Goodman, Associate Director for Systems Quality and Outcomes - Surgical Services, Mount Sinai Health System- "Sharing is Caring- Moving from zero-sum competition to positive-sum competition and collaboration in healthcare"
Who competes in healthcare?
Physicians, Suppliers, Payers, Hospitals.
Who competes in healthcare?
It can eliminate process inefficiencies and failing enterprises. It can reduce production costs. It can increase quality and value of care.
The cons of competition - the zero sum game: Porter and Teisberg (HBR, 2004) showed that a focus on cost reduction and satisfaction surveys, as well as the use of improper incentives (to Providers and Payers) can produce zero sum competition. Zero sum competition produces winners (large networks) and losers (small independent safety net facilities). Value is typically divided and not created. Cost is shifted from the strong (payer) to the weak (self-pay patients). Access to HC services is restricted (esp. for poorer/under-insured or self-pay patients). Innovation is often stifled to reduce costs.
Positive-sum competition (Porter and Teisberg, 2004): akes a holistic view of disease management (patient care journey) and the HC ecosystem . Produces a healthier level of competition/specialization. Generate appropriate markets
Generates data transparency
And then came Covid-19: SHOCK/HORROR - competitors became collaborators. Departmental silos tumbled - clinical units, finance, IT, supply chain, innovation talked to each other. Bureaucracy was overridden. Innovation was unleashed. Loose networks became cohesive. Competing systems collaborated- sharing clinical/supply chain data, models, best practices HCNs collaborated with government, public health systems, community organizations.
Collaboration in surgery: KEY QUESTION: how we measure HC quality - structures, processes and outcomes (surgical complication rates, PROs). NSQIP - surgical outcomes database established by the ACS in 1994 (VA) and 2005 (non-VA): 700+ hospitals in USA and beyond . MSQC - similar database established in Michigan in 2005: 70+ hospitals, 6500+ surgeons, 50,000+ cases entered per year, has established best practice guidelines (hernia, colorectal surgery etc).
Benefits of collaborative databases:
Thanh (2019) showed in 22,000 ortho/GU/GYN/CR patients from 5 hospitals a general improvement in SSI, UTI, LOS, readmission rate after adoption of NSQIP. Cohen (2015) showed that 5 years of NSQIP participation can reduce mortality in large hospitals by 14 patients/year and reduce total # of complications by 300/year. Robust QI efforts must be in place to work on deficiencies identified by NSQIP for full effect. This combined action plan reduces morbidity but NOT mortality after surgery.
MSQC results 2008-2016:
Reduced SSIs by 42% (2012-2016)
Reduced sepsis rates by 14% (2016-2017). Reduced readmission rates by 10% (2008-2016). Reduced LOS by 17% (2008-2016)
In this report, ISR leverages the insights and real-world experiences investigative sites have with electronic medical records (EMRs) and clinical trials. The report examines how sites currently use EMRs for various clinical trial activities and provides recommendations to improve trial efficiency.
Safti net overview ahrq stakeholders mtg oct 2011Marion Sills
SAFTINet: Scalable Architecture for Federated Translational Inquiries Network
An overview presented by Marion R. Sills, MD to the Agency for Healthcare Research and Quality's Effective Health Care Stakeholders Group, October 2011
The Child Protection Program at UMass Memorial Children's Medical Center in Worcester, MA, provides care for children suspected of abuse or maltreatment.
The hospitals of UMass Memorial Health Care work with their respective communities to address identified needs of the medically underserved. Each hospital offers a number of community benefits programs that link our vast clinical and community resources to overcome barriers to accessing care and addressing health disparities. Our 2013 Community Benefits Report highlights some of these programs that meet the needs of vulnerable populations.
Check out some of the latest Showcase Ideas from across the Medical Center!
Ideas listed on the slideshow have been implemented through the department’s Idea System, and entered into the UMass Memorial Health Care Implemented Ideas Database. If you’d like to showcase your team’s idea, please email Lauren Russell.at lauren.russell@umassmemorial.org
The Women’s Heart Health Program at UMass Memorial Medical Center provides cardiac care designed specifically for women.This dedicated clinic focuses on all aspects of cardiology for women, from preventive care to the treatment of complex conditions.
Our Anticoagulation Center is moving to the Hahnemann Campus July 18, 2014 We look forward to providing you the quality care you have come to trust at our new location.
All it takes is 28 days to get your heart health back on track. Follow the Heart and Vascular Center of Excellence calendar with exercise tips, recipes and information you need to get heart healthy.
The Memorial Campus of our Medical Center applied for, and was awarded, a GWTG silver award for achieving the 85 percent adherence for 12 months. This award is presented by the American Heart Association.
Our transcatheter aortic valve implantation (TAVI) program offers a possible alternative to open heart surgery for patients with severe, symptomatic aortic stenosis who are high risk for surgery or who are inoperable.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Light House Retreats: Plant Medicine Retreat Europe
Force TJR Quality Overview 2014
1. www.force-tjr.org
Questions? Call 855 993 6723 (855 99FORCE)
FORCE-TJR QI TM
Quality. Value. Builds on lessons learned from research.
CMS is publicly reporting hospital-specific TJR readmission and complication rates on the Hospital Compare website. ARE YOU PREPARED FOR THE NEXT PUBLIC DATA RELEASE?
FORCE-TJR - The competitive edge FORCE-TJR QI, (Function and Outcomes Research for Comparative Effectiveness in Total Joint Replacement) is the first U.S. TJR registry to provide national norms and risk-adjusted data for hospitals and surgeons to guide quality monitoring in total joint replacement. Similar to STS and NSQCIP, FORCE-TJR QI measures outcomes and adverse events, risk adjusts for co- morbidities, and provides comprehensive, comparative data to improve patient care, meet reporting requirements, compare performance to peer surgeons/institutions, secure quality incentive payments.
FORCE-TJR - The data to prove quality Risk-adjusted, national norms and comparative reports to document patient reported outcomes (PROs), readmission rates, adverse events, and implant survival (compared to national benchmarks). Data to answer: How do my patients compare to other patients/other sites on:
Pre-op risk factors; pre-TJR pain and function; risk-adjusted post-surgical pain and function? Data to receive incentives from CMS (PQRS) and other pay-for-performance programs. Implant performance reports based on US data.
FORCE-TJR - The tools to succeed State-of-the-art web-based platform - compatible with ANY electronic medical record. Collect valuable data without affecting patient flow or efficiency. Benchmark data collected from more than 25,000 diverse TJR patients in 22 states; high and low volume hospitals; 75% of surgeons are community-based. Proven methods to collect complete pre- and post-operative patient-reported outcomes (PROs), readmissions, and adverse events. Identifies adverse events and readmission/ER visits at non-surgical hospitals.
Learn more in our PRO Workshops* on Tuesday December 9!
You can also email us at force-tjr@umassmed.edu
*A15 from 9:30-10:45am and B15 from 11:15am-12:30pm - Grand Ballroom: Salon 7